Nothing Special   »   [go: up one dir, main page]

GB815381A - Antibiotic designated nucleocidin and preparation thereof - Google Patents

Antibiotic designated nucleocidin and preparation thereof

Info

Publication number
GB815381A
GB815381A GB11779/56A GB1177956A GB815381A GB 815381 A GB815381 A GB 815381A GB 11779/56 A GB11779/56 A GB 11779/56A GB 1177956 A GB1177956 A GB 1177956A GB 815381 A GB815381 A GB 815381A
Authority
GB
United Kingdom
Prior art keywords
antibiotic
nucleocidin
aqueous
per cent
carbon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB11779/56A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of GB815381A publication Critical patent/GB815381A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/20Bacteria; Substances produced thereby or obtained therefrom
    • A01N63/28Streptomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A new antibiotic Nucleocidin, effective against trypanosomes, amoebae and gram negative and gram positive bacteria is produced by aerobically fermenting an aqueous nutrient medium containing a source of carbon, nitrogen <PICT:0815381/IV (b)/1> <PICT:0815381/IV (b)/2> and nutrient salts with a nucleocidin-producing strain of Streptomyces calvus nov. spec. The initial pH of the medium is 6.0 to 8.0, the temperature of fermentation 17-42 DEG C. and preferably 26-30 DEG C. and the duration of fermentation 48 hours. Specified carbon sources are starch, sugars such as lactose, sucrose, molasses; alcohols such as glycerol and mannitol and organic acids such as citric and acetic acid. Nitrogen sources are proteins, e.g. casein, processes, peptones, peptides, casein hydrolysates, corn steep liquor, soya bean meal, gluten, cottonseed meal, fish meal, meat extracts, yeast extracts, amino acids, urea, ammonium and nitrate salts and others. Nutrient salts are sodium, potassium calcium and magnesium, chloride, sulphate and phosphate and the trace metals boron, cobalt, iron, copper, zinc, manganese, chromium and molybdenum. Nucleocidin is recovered by (a) adsorption or (b) solvent extraction or a combination of (a) and (b). Adsorption on activated carbon is preferred using a pH of 6.5 to 8.0 and eluting with a polar solvent especially aqueous acetone. Other eluants are aqueous methanol of pH 2 to 3 to 9.0; ethanol, propanol, butanol, beta methoxyethanol, beta ethoxy ethanol, dilute acids such as hydrochloric and acetic, pyridine and aqueous phenol. The filtered fermentation liquor may be stirred with the activated carbon and filtered, the cake being stirred with the eluant to extract the antibiotic. Alternatively, the fermentation liquor is passed down a column of the activated carbon, washed with water and then eluted. Nucleocidin can be absorbed on cationic exchange resins. The eluate may be concentrated or lyophilized and the crude antibiotic used as such for the treatment of animals, or further purified. Further purification may be by activated carbon chromatography, a solution of the antibiotic in e.g. 50 per cent aqueous acetone being passed down the column of carbon, which is developed with the same solvent to remove impurities, and then with a solvent containing a higher proportion of the acetone to remove the nucleocidin. The antibiotic may be isolated from a clarified fermentation broth, or purified from an aqueous solution, if desired after saturating with ammonium sulphate, by extraction with n-butanol. Crystals are produced by adjusting the pH of an aqueous acid solution of the antibiotic to pH 4.0. Examples relate to the preparation of the hydrochloride, sulphate, picrate and helianthate salts of the antibiotic. Nucleocidin is weakly basic, contains carbon 34.03 per cent, hydrogen 4.05 per cent, nitrogen 21.60 per cent, sulphur 8.30 per cent and oxygen 32.02 per cent, possibly C11H15-16N6O8S; [a ]24.5 = -33.3 (acid aqueous ethanol); soluble in water especially at pH 9.25, methanol and acetone, sparingly soluble in n-butanol, ethyl acetate, benzene and ether; it is stable in water at pH 3, pH 7 and pH 9 at room temperatures; the ultraviolet absorption at pH 7.0 (Fig. 2) shows a maximum absorption peak at 256 millimicrons; the infrared absorption spectrum (Fig. 1) shows absorption bands at the following frequencies expressed in microns: 2.87, 2.99, 3.13, 5.96, 6.18, 6.29, 6.58, 6.75, 7.00, 7.24, 7.36, 7.45, 7.71, 7.99, 8.24, 8.46, 8.76, 8.96, 9.26, 9.56, 9.83, 9.95, 10.20, 10.54, 11.15, 11.87, 12.55, 12.71, 13.16, 13.63 and 14.00.
GB11779/56A 1955-04-27 1956-04-18 Antibiotic designated nucleocidin and preparation thereof Expired GB815381A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US815381XA 1955-04-27 1955-04-27

Publications (1)

Publication Number Publication Date
GB815381A true GB815381A (en) 1959-06-24

Family

ID=22164817

Family Applications (1)

Application Number Title Priority Date Filing Date
GB11779/56A Expired GB815381A (en) 1955-04-27 1956-04-18 Antibiotic designated nucleocidin and preparation thereof

Country Status (1)

Country Link
GB (1) GB815381A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824657A (en) * 1997-03-18 1998-10-20 Cubist Pharmaceuticals, Inc. Aminoacyl sulfamides for the treatment of hyperproliferative disorders

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824657A (en) * 1997-03-18 1998-10-20 Cubist Pharmaceuticals, Inc. Aminoacyl sulfamides for the treatment of hyperproliferative disorders

Similar Documents

Publication Publication Date Title
Dion et al. 6-Diazo-5-oxo-L-norleucine, A New Tumor-inhibitory Substance. II. 1 Isolation and Characterization2
GB1083662A (en) A novel antibiotic, methods for its production and therapeutic compositions containing it
SU578014A3 (en) Method of preparing p,q,r and u rifamycin
GB2179042A (en) Ginsenoside-Rd
GB715362A (en) Improvements in or relating to antimicrobial agent
GB877732A (en) The antibiotic rifomycin, its components and methods of preparing same
GB815381A (en) Antibiotic designated nucleocidin and preparation thereof
GB846933A (en) New antifungal substance, pimaricin, and method of producing same
Noma et al. Isolation and characterization of D-alanyl-D-alanine from tobacco leaves
US4423218A (en) Antibiotic neplanocin A
GB1038242A (en) Bleomycin and processes for preparation thereof
US3743580A (en) Antibiotic,negamycin,and processes for the preparation thereof
US2505053A (en) Method for recovering grisein
GB901830A (en) A new antibiotic danubomycin and a process for its manufacture
Suzuki et al. Neopterin-3'-β-D-glucuronide: Isolation from Azotobacter agilis
US2835675A (en) Elymoclavine and manufacture of ergot alkaloids by culture
CN112409426A (en) Preparation method of sisomicin sulfate
US3089816A (en) Lemacidine and process for its manufacture
US2571896A (en) Recovery of riboflavin
GB764198A (en) The antibiotic vengicide and processes for the preparation of the antibiotics oxytetracycline and vengicide
US3655877A (en) Plurallin and production thereof
GB793797A (en) Improvements in or relating to antibiotics
GB897581A (en) Preparation of a new antibiotic aspartocin
GB768364A (en) A new antibiotic anisomycin
GB757089A (en) Improvements in or relating to antibiotics